Related Experiment Video
Updated: Aug 15, 2025
11:34
Exploring Sequence Space to Identify Binding Sites for Regulatory RNA-Binding Proteins
Published on: August 9, 2019
6.7K
Aptamer Technology and Its Applications in Bone Diseases.
Xiangzhong Liu1, Jing Hu2, Yu Ning3
1Department of Orthopaedics, Wuhan Third Hospital, Tongren Hospital of Wuhan University, Wuhan, China.
Cell Transplantation
|January 2, 2023
Summary
Aptamers, versatile nucleic acid tools, offer advantages over antibodies for diagnostics and therapeutics. This review explores optimizing their selection and modification for broader clinical applications, especially in bone diseases.
Area of Science:
- Biotechnology and Molecular Biology
- Nucleic Acid Chemistry
- Therapeutic Development
Background:
- Aptamers are nucleic acid-based ligands selected via Systematic Evolution of Ligands by Exponential Enrichment (SELEX).
- They offer advantages over antibodies, including chemical stability and ease of production.
- Despite potential in diagnostics and therapeutics, limitations in aptamer and SELEX technology hinder clinical use.
Purpose of the Study:
- To review methods for optimizing SELEX technology and aptamer modification.
- To enhance aptamer selection success rates and improve their characteristics.
- To explore the application of aptamers in treating bone diseases.
Main Methods:
- Review of literature on SELEX optimization techniques.
- Analysis of aptamer modification strategies.
- Survey of aptamer applications in bone disease research.
Main Results:
- Optimized SELEX protocols and aptamer modifications can significantly improve selection efficiency and aptamer properties.
- Aptamers show promise for diagnosing and treating various clinical conditions, including bone diseases.
- Addressing current limitations is crucial for advancing aptamer-based therapies.
Conclusions:
- Aptamer technology, when optimized, presents a powerful alternative to antibodies for medical applications.
- Further development in SELEX and aptamer modification will accelerate the translation of aptamers into clinical practice.
- Aptamers hold significant therapeutic potential for bone diseases.
More Related Videos
Related Concept Videos
02:57Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
01:27Transducer Mechanism: Enzyme-Linked Receptors
2.6K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
2.6K
01:40Bone Remodeling
38.4K
Bone remodeling is a continuous and balanced process of bone resorption by osteoclasts and bone formation by osteoblasts. In adults, it helps maintain bone mass and calcium homeostasis. While mechanical stress can stimulate turnover as part of the normal maintenance and reparative process, several hormones also regulate bone remodeling.
38.4K
01:55Bone Structure
48.9K
Within the skeletal system, the structure of a bone, or osseous tissue, can be exemplified in a long bone, like the femur, where there are two types of osseous tissue: cortical and cancellous.
48.9K
00:59Gene Therapy
25.7K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
25.7K